novo nordisk semaglutide shortage FDA: Ozempic and Wegovy drug is over FDA ends semaglutide shortage, closing

Short-Term Use for Specific Goals Some patients may use GLP-1 medications for a shorter period to achieve specific weight loss goals, such as losing a certain amount of weight for an event or to improve a health condition (for example, reducing blood pressure)

Only under the guidance of a qualified healthcare professional

A new Medicare program that began July 1, 2026, may make certain GLP-1 weight-management medications available to eligible people with Medicare prescription drug coverage for a $50 monthly copay

Abdominal obesity also reduces lung volumes, making respiratory efforts less effective at keeping the airway open

And then we have your participatory athletes your 13 or 14 hour plus IRONMAN finishers in the deepest age groups